Kindly MD - רווח החברה לפני מסים, ריבית ופחת KDLY

The micro-cap status of Kindly MD, Inc. (KDLY) limits financial transparency, requiring management to prove its scaling capabilities. Analyzing the EBITDA on GURU.Markets, we see that the 0.00 level is the current figure. Kindly MD, Inc. (KDLY) is developing cannabis therapy to combat opioid addiction, integrating its programs through partnerships with insurance agencies and specialized medical centers.

This indicator tracks the daily cash flow generated by core operations, serving as a precise gauge of the business's operational efficiency and liquidity. By analyzing the history of operating profit in cash terms, an investor will see that due to the physical constraints of Kindly MD, Inc. (KDLY) clinics, capital growth depends exclusively on network expansion rather than the optimization of existing capacities.